Epidemiology of Transfusion Related Acute Lung Injury in France: Preliminary Results
Author(s) -
P. Renaudier,
S. Schlanger,
Mai-Phuong Vo,
N. Ounnoughène,
Pascal Breton,
S. Chèze,
Albane Girard,
Lisette Hauser,
Jean Fran ccedil ois Legras,
Hélène OdentMalaure,
Danielle Rebibo,
C. Waller,
Béatrice Willaert,
C. Caldani
Publication year - 2008
Publication title -
transfusion medicine and hemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.971
H-Index - 39
eISSN - 1660-3818
pISSN - 1660-3796
DOI - 10.1159/000117812
Subject(s) - transfusion related acute lung injury , medicine , epidemiology , intensive care medicine , blood transfusion , emergency medicine , lung , pulmonary edema
SUMMARY: The French Hemovigilance Network has been established in 1994 and records all adverse events associated with the transfusion of a labile blood products (LBP) regardless of their severity. From 1994 to 2006 35,423,172 LBP were issued, 85,812 adverse transfusion reactions notified, and 139 cases of transfusion related acute lung injury (TRALI) observed. The LBP most at risk is fresh frozen plasma (FFP), followed by platelets concentrates (PC) and packed red cells (PRC). However, because the use of FFP is not frequent in France, it only accounts for about 10% of TRALI, whereas PRC and PC are involved in the remaining cases. In no case, pooled FFP treated with solvent-detergent were involved. Patients' profiles are peculiar with a high disease burden. Therefore, targeting a prevention policy only on FFP would result in a marginal reduction of TRALI in France.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom